Hims & Hers (HIMS) stock collapsed after confirming it will stop selling compounded weight-loss drugs. Despite strong revenue ...

U.S. stock futures (ES00) (NQ00) weakened after the S&P 500 SPX finished at its lowest level since mid-January. Bitcoin (BTCUSD) traded below $90,000, and the yield on the 10-year Treasury declined.

Shares of Viking Therapeutics VKTX rose nearly 8% on Friday after several third-party reports suggested that it was being ...

Shortages of Ozempic and Wegovy that have been in place for more than two years have been resolved, as supplies of the ...

For decades, scientists believed that infections were determined solely by viruses and bacteria. But Professor Jean-Laurent ...

The U.S. Food and Drug Administration said on Friday there was no longer a shortage of Novo Nordisk’s popular weight-loss and ...

The clinical Phase I study conducted in the NEX-22 project with good results and focus on the evaluation with Novo Nordisk has provided a good starting point for 2025. Significant events during the fo ...

The big pharma sector is one that’s generally fallen out of favor for many investors over the past few decades, as large ...

The FDA’s decision will threaten the ability of compounding pharmacies to make far cheaper, unbranded versions of the ...

Novo Nordisk (NVO) announced that the U.S. Food and Drug Administration has determined the shortage of Wegovy and Ozempic is resolved. “The ...

Shares of Novo Nordisk (NVO) are up 6% in pre-market trading after a FDA drug shortage notice indicated that a shortage of several versions of ...

Novo Nordisk A/S’s weight-loss and diabetes drugs are no longer in short supply, US regulators said, a decision that’s ...